Deutsche Bank’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,779
Closed -$167K 5736
2019
Q1
$167K Buy
+1,779
New +$156K ﹤0.01% 4092
2018
Q3
Sell
-750
Closed -$60K 5774
2018
Q2
$60K Sell
750
-1,500
-67% -$125K ﹤0.01% 4721
2018
Q1
$200K Buy
2,250
+450
+25% +$43.2K ﹤0.01% 4199
2017
Q4
$187K Buy
1,800
+596
+50% +$67.3K ﹤0.01% 4060
2017
Q3
$175K Sell
1,204
-561
-32% -$76.4K ﹤0.01% 3947
2017
Q2
$229K Buy
1,765
+1,636
+1,268% +$200K ﹤0.01% 3857
2017
Q1
$16K Buy
+129
New +$15.4K ﹤0.01% 4561
2016
Q4
Sell
-3,000
Closed -$313K 5317
2016
Q3
$313K Buy
+3,000
New +$325K ﹤0.01% 3421
2016
Q2
Sell
-40
Closed -$4K 5620
2016
Q1
$4K Sell
40
-260
-87% -$26.8K ﹤0.01% 5001
2015
Q4
$35K Hold
300
﹤0.01% 4570
2015
Q3
$32K Sell
300
-969
-76% -$120K ﹤0.01% 4623
2015
Q2
$146K Hold
1,269
﹤0.01% 4044
2015
Q1
$146K Buy
1,269
+237
+23% +$28.3K ﹤0.01% 3959
2014
Q4
$115K Hold
1,032
﹤0.01% 4641
2014
Q3
$97K Hold
1,032
﹤0.01% 4520
2014
Q2
$88K Hold
1,032
﹤0.01% 4643
2014
Q1
$14K Buy
1,032
+864
+514% +$68.4K ﹤0.01% 4945
2013
Q4
$5K Sell
168
-1,200
-88% -$95K ﹤0.01% 5046
2013
Q3
$27K Buy
1,368
+1,200
+714% +$84.1K ﹤0.01% 4839
2013
Q2
$2K Buy
+168
New +$10.1K ﹤0.01% 5220

Other funds holding CELG

Deutsche Bank's CELG Position: Q4 2019 in Review

Deutsche Bank sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,750,234 shares — an estimated $273M sold.

Deutsche Bank first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.21B in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Deutsche Bank reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Deutsche Bank sold 2,750,234 Celgene Corp shares in Q4 2019, an estimated $273M.
  • Deutsche Bank first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Deutsche Bank's Celgene Corp position peaked at $1.21B in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Deutsche Bank's 13F filing for Q4 2019, filed 14 Feb 2020.